Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

FDA grants manufacturing approval for bulk ciclosporin

July 8, 1997

Preliminary results reported for Cortecs' Flustat

July 7, 1997

Natural immunosuppressive agent disclosed by Kyowa Hakko

July 3, 1997

Preclinical results reported for type I diabetes vaccine

June 30, 1997

ImmuLogic postpones Allervax Ragweed trial

June 30, 1997

North American Vaccine seeks FDA approval for DTaP-IPV vaccine trial

June 30, 1997

Ranitidine for infectious mononucleosis

June 24, 1997

Merck & Co.'s new immunosuppressants

June 24, 1997

Novel immunosuppressants prepared by Merck & Co.

June 20, 1997

NIH-supported study evaluates efficacy and safety of acellular pertussis vaccine in adults

June 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...